首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1308235

2023-2028年按產品類型（心臟標誌物檢測、分析儀）、終端用戶（醫院、診斷實驗室及其他）和地區分類的心臟PoC檢測設備市場

Cardiac PoC Testing Devices Market by Product Type (Cardiac Markers Test, Analyzers), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2023-2028

出版日期: 2023年07月05日 | 出版商:

IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

市場概述：

2022年，全球心臟PoC測試設備市場規模達到17.5億美元。展望未來，IMARC Group預計到2028年，該市場規模將達到24.7億美元，2023-2028年間的年複合成長率（CAGR）為6.10%。煙草消費過多導致心血管疾病發病率上升；檢測腦鈉肽，激酶，合成肌鈣蛋白和乳酸脫氫酶同工酶的需求上升；以及醫療行業的蓬勃發展是推動市場發展的一些關鍵因素。

心臟照護端（PoC）檢測設備是創新的攜帶式醫療儀器，旨在快速準確地診斷心臟疾病。它們結構緊湊、使用方便，可提供即時結果，使醫生能夠就患者護理做出迅速、明智的決定。它們為醫護人員提供了在患者床旁進行診斷測試的能力，消除了對實驗室測試的需求，縮短了關鍵心臟評估的周轉時間。它們能在幾分鐘內提供準確可靠的結果，從而提高臨床工作流程的效率。它們有助於進行各種診斷測試，包括心臟生物標記分析、凝血監測、膽固醇分析和電解質測量。它們有助於立即獲得檢測結果，從而更有效地分流病人，減少急診科的擁擠程度，最佳化資源分配。由於減少了對集中實驗室的依賴，最大限度地降低了與樣本運輸、實驗室人員和基礎設施相關的成本，全球對心臟PoC檢測設備的需求正在上升。

心臟PoC檢測設備市場趨勢：

目前，由於過度吸煙和飲酒導致的心血管疾病發病率上升是促進市場成長的關鍵因素之一。此外，全球使用心臟PoC檢測設備檢測心肌梗死和冠狀動脈症候群的人數也在增加。這一點以及蓬勃發展的醫療行業為市場成長提供了支持。此外，越來越多的人使用這些設備來鑑定腦鈉肽，激酶，合成肌鈣蛋白，以及心力衰竭時產生的乳酸脫氫酶同工酶，這些都對市場產生了積極的影響。除此以外，主要企業正致力於推出基於智慧手機的心血管疾病檢測。他們還在開發技術先進的心臟生物標記分析儀，從而促進了市場的成長。此外，對心臟分析儀的需求也在增加，因為它們有軟體提供內部標準，以考慮到測試中固有的膜變異性，並整合了LCD顯示螢幕，以方便用戶和提高視覺清晰度。再加上分析儀能夠量化全血、血清和血漿中生物標記的濃度，有助於臨床診斷，這些都推動了市場的成長。此外，PoC檢測設備技術的不斷進步也提供了一個有利的市場前景。

本報告回答的關鍵問題

到目前為止，全球心臟PoC檢測設備市場的表現如何？
全球心臟PoC檢測設備市場的驅動因素、限制因素和機會是什麼？
每個驅動因素、限制因素和機會對全球心臟PoC檢測設備市場的影響是什麼？
哪些是主要的區域市場？
哪些國家的心臟PoC檢測設備市場最具吸引力？
基於產品類型的市場細分是什麼？
哪種產品類型在心臟PoC檢測設備市場最具吸引力？
基於終端用戶的市場分類是怎樣的？
哪個是心臟PoC檢測設備市場最具吸引力的終端用戶？
全球心臟PoC檢測設備市場的競爭結構是什麼？
全球心臟PoC檢測設備市場的主要參與者/公司有哪些？

北美洲
- 美國
- 市場趨勢
- 市場預測
- 加拿大
- 市場趨勢
- 市場預測
亞太地區
- 中國
- 市場趨勢
- 市場預測
- 日本市場
- 市場趨勢
- 市場預測
- 印度市場
- 市場趨勢
- 市場預測
- 韓國
- 市場趨勢
- 市場預測
- 澳大利亞
- 市場趨勢
- 市場預測
- 印尼
- 市場趨勢
- 市場預測
- 其他市場
- 市場趨勢
- 市場預測
歐洲
- 德國
- 市場趨勢
- 市場預測
- 法國
- 市場趨勢
- 市場預測
- 英國
- 市場趨勢
- 市場預測
- 義大利市場
- 市場趨勢
- 市場預測
- 西班牙
- 市場趨勢
- 市場預測
- 俄羅斯
- 市場趨勢
- 市場預測
- 其他市場
- 市場趨勢
- 市場預測
拉丁美洲
- 巴西市場
- 市場趨勢
- 市場預測
- 墨西哥市場
- 市場趨勢
- 市場預測
- 其他市場
- 市場趨勢
- 市場預測
中東和非洲
- 市場趨勢
- 各國市場細分
- 市場預測

第九章：驅動因素、限制因素和機會

驅動因素
驅動因素
限制因素
機會

第10章：價值鏈分析

第十一章：波特五力分析

五力分析概述
買家議價能力
供應商議價能力
競爭程度
新進入者的威脅
替代品的威脅

第十二章：價格分析

第十三章：競爭格局

市場結構
主要競爭者
主要競爭者簡介
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financials
- SWOT Analysis
- ACON Laboratories Inc.
- Company Overview
- Product Portfolio
- Alfa Scientific Designs Inc.
- Company Overview
- Product Portfolio
- Bio-Rad Laboratories Inc.
- Company Overview
- Product Portfolio
- Financials
- SWOT Analysis
- Danaher Corporation
- Company Overview
- Product Portfolio
- Financials
- SWOT Analysis
- F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Financials
- LifeSign LLC
- Company Overview
- Product Portfolio
- Nano-Ditech Corporation
- Company Overview
- Product Portfolio
- Nexus-Dx Inc.
- Company Overview
- Product Portfolio

簡介目錄

Product Code: SR112023A7971

Market Overview:

The global cardiac PoC testing devices market size reached US$ 1.75 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.47 Billion by 2028, exhibiting a growth rate (CAGR) of 6.10% during 2023-2028. The growing prevalence of cardiovascular diseases due to excessive consumption of tobacco; rising need to detect brain natriuretic peptides, kinase, synthesizing troponin, and lactate dehydrogenase isoenzymes; and the thriving medical industry represent some of the key factors driving the market.

Cardiac point-of-care (PoC) testing devices are innovative and portable medical instruments designed for the rapid and accurate diagnosis of cardiac conditions. They are compact, user-friendly, and offer real-time results, enabling physicians to make prompt and informed decisions about patient care. They provide healthcare professionals with the ability to conduct diagnostic tests at the bedside of patients, eliminate the need for laboratory-based testing, and reduce turnaround times for critical cardiac assessments. They enhance the efficiency of clinical workflows by delivering accurate and reliable results within minutes. They assist in performing a variety of diagnostic tests, including cardiac biomarker analysis, coagulation monitoring, cholesterol profiling, and electrolyte measurement. They aid in obtaining immediate test results that facilitate more efficient patient triage, reduce overcrowding in emergency departments, and optimize resource allocation. As they minimize costs associated with sample transportation, lab personnel, and infrastructure by reducing the reliance on centralized laboratories, the demand for cardiac PoC testing devices is rising worldwide.

Cardiac PoC Testing Devices Market Trends:

At present, the rising prevalence of cardiovascular diseases due to the excessive consumption of tobacco and alcohol represents one of the crucial factors bolstering the growth of the market. Moreover, there is an increase in the utilization of cardiac PoC testing devices to detect myocardial infarction and coronary syndromes around the world. This, along with the thriving medical industry, is supporting the growth of the market. In addition, the growing employment of these devices to identify brain natriuretic peptides, kinase, synthesizing troponin, and lactate dehydrogenase isoenzymes that are generated during heart failure is positively influencing the market. Besides this, key players are focusing on launching smartphone-based tests for cardiovascular diseases. They are also developing technologically advanced cardiac biomarker analyzers, which is bolstering the growth of the market. Additionally, there is a rise in the demand for cardiac analyzers, as they have software to provide an internal standard to account for membrane variability that is intrinsic to tests and integrated LCD displays for user convenience and visual clarity. This, coupled with the ability of analyzers to quantify the concentration of biomarkers in whole blood, serum, and plasma, which helps in clinical diagnosis, is impelling the growth of the market. Furthermore, the growing technological advancements in PoC testing devices are offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cardiac PoC testing devices market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type and end user.

Product Type Insights:

Cardiac Markers Test

Cardiac Troponin (cTn) Test

Myoglobin Test

Creatine Kinase MB Isoenzyme (CK-MB) Test

Combinational Test Kits

Brain Natriuretic Peptide (BNP) Test

Analyzers

The report has provided a detailed breakup and analysis of the cardiac PoC testing devices market based on the product type. This includes cardiac markers test [cardiac troponin (cTn) test, myoglobin test, creatine kinase MB isoenzyme (CK-MB) test, combinational test kits, and brain natriuretic peptide (BNP) test] and analyzers. According to the report, analyzers represented the largest segment.

End User Insights:

Hospitals

Diagnostic Laboratories

Others

A detailed breakup and analysis of the cardiac PoC testing devices market based on the end user has also been provided in the report. This includes hospitals, diagnostic laboratories, and others. According to the report, diagnostic laboratories accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cardiac PoC testing devices. Some of the factors driving the North America cardiac PoC testing devices market included the growing cardiovascular burden among the population, increasing healthcare expenditure, rising geriatric population, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global cardiac PoC testing devices market. Detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, ACON Laboratories Inc., Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, LifeSign LLC, Nano-Ditech Corporation, Nexus-Dx Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

How has the global cardiac PoC testing devices market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global cardiac PoC testing devices market?
What is the impact of each driver, restraint, and opportunity on the global cardiac PoC testing devices market?
What are the key regional markets?
Which countries represent the most attractive cardiac PoC testing devices market?
What is the breakup of the market based on the product type?
Which is the most attractive product type in the cardiac PoC testing devices market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the cardiac PoC testing devices market?
What is the competitive structure of the global cardiac PoC testing devices market?
Who are the key players/companies in the global cardiac PoC testing devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Cardiac PoC Testing Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Cardiac Markers Test
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Cardiac Troponin (cTn) Test
  - 6.1.2.2 Myoglobin Test
  - 6.1.2.3 Creatine Kinase MB Isoenzyme (CK-MB) Test
  - 6.1.2.4 Combinational Test Kits
  - 6.1.2.5 Brain Natriuretic Peptide (BNP) Test
- 6.1.3 Market Forecast
6.2 Analyzers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by End User

7.1 Hospitals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Diagnostic Laboratories
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

9.1 Overview
9.2 Drivers
9.3 Restraints
9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Abbott Laboratories
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 ACON Laboratories Inc.
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
- 13.3.3 Alfa Scientific Designs Inc.
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
- 13.3.4 Bio-Rad Laboratories Inc.
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 Danaher Corporation
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 Financials
  - 13.3.5.4 SWOT Analysis
- 13.3.6 F. Hoffmann-La Roche AG
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
  - 13.3.6.3 Financials
- 13.3.7 LifeSign LLC
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
- 13.3.8 Nano-Ditech Corporation
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
- 13.3.9 Nexus-Dx Inc.
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio